Sleep Disturbances and Pulmonary Artery/Aorta Diameter in Scleroderma Patient
Sponsor
Northwell Health (Other)
Overall Status
Completed
CT.gov ID
NCT00566137
Collaborator
(none)
50
12
Study Details
Study Description
Brief Summary
To determine sleep disturbance, pulmonary function test, 6 minute walk, echocardiogram abnormality, arterial blood gas, ventilation/perfusion scan of the chest in Scleroderma patient with Pulmonary Hypertension.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
|
Detailed Description
As above
Study Design
Study Type:
Observational
Actual Enrollment
:
50 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Sleep Disturbances and Pulmonary Artery/Aorta Diameter in Scleroderma Patient
Study Start Date
:
Feb 1, 2006
Actual Study Completion Date
:
Feb 1, 2007
Outcome Measures
Primary Outcome Measures
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- Patient must have Scleroderma
Exclusion Criteria:
- Patients who do not have Scleroderma
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Northwell Health
Investigators
- Principal Investigator: Arunabh Talwar, MD, Northwell Health
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00566137
Other Study ID Numbers:
- 06-08-018
- NS-LIJHS IRB #06-08-018
First Posted:
Dec 3, 2007
Last Update Posted:
Mar 9, 2010
Last Verified:
Mar 1, 2010
Keywords provided by ,
,
Additional relevant MeSH terms: